Lazaros J Lekakis MD

Assistant Professor, Medicine, University of Miami Leonard M. Miller School of Medicine

1475 Nw 12th AveSuite 3300 (D8-4)Miami, FL 33136
Phone+1 305-748-0641

Dr. Lekakis is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lekakis' full profile Already have an account?

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1999 - 2002
University of AthensClass of 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2010 - 2027
KY State Medical License 2006 - 2011
IL State Medical License 1999 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease
COMPLETED
PHASE2
Axicabtagene Ciloleucel Expanded Access Study
APPROVED_FOR_MARKETING
STRIDE Biorepository Start of enrollment: 2017 Mar 13
UNKNOWN
Roles: Contact

Publications & Presentations

PubMed

Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Lubna Osman-Kardash, Ahmed Alnajar, Anthony D Anderson, Ellen Madarang, Mikkael Sekeres
American Journal of Hematology. 2026-07-28
Transfusion support after CAR-T cell therapy: Real-world patterns across commercial products and disease groups.
Jay Patel, Denise L Pereira, Damian Green, Amer Beitinjaneh, Noa G Holtzman
Transfusion Clinique Et Biologique. 2026-07-18
False-positive HIV-1 RNA detection following obecabtagene autoleucel.
Jose F Camargo, Anthony D Anderson, Jay Spiegel, Mohammed Raja, Michele I Morris
Bone Marrow Transplantation. 2026-06-29

Abstracts/Posters

CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post_Axi-Cel
Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

ASH 2025 Tip Sheet: Sylvester Researchers Contribute to More Than 35 Oral Presentations at ASH Annual MeetingNovember 11th, 2025
Cellular Therapy Developed for Cancer Now Being Tested in Autoimmune DiseaseMarch 2nd, 2026